Home

Ramtin Agah, Chief Medical Officer: RenovoRx RNXT Buy · Filed 25/04/17

Trade details

Type
Insider buy
Amount
$13,500
Shares · price
15,000 sh · $0.90 a share
Held after
1,113,460 sh
Trade date
25/04/15
Filed
25/04/17
Days to filing
2 days

First buy since 2023

Insiders buying this week
4 insiders
Holding change
+1.4%

RenovoRx trades, last 26 weeks

What else happened in RenovoRx around then

Filed or reported within 30 days of the trade day · 25/03/16~25/05/15

Ramtin Agah's recent trades

  • Ramtin Agah

    BuyRenovoRx

    $10K

    Filed 01/22

  • Ramtin Agah

    BuyRenovoRx

    $8,424

    Filed 01/05

  • Ramtin Agah

    BuyRenovoRx

    $170

    Filed 01/02

  • Ramtin Agah

    BuyRenovoRx

    $10.2K

    Filed 25/12/17

  • Ramtin Agah

    BuyRenovoRx

    $9,600

    Filed 25/12/08